• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用情景开发和评估法估计法布里病的健康状态效用值

Estimation of Health State Utility Values in Fabry Disease Using Vignette Development and Valuation.

作者信息

Hughes Derralynn, Lenny Andrew, Shah Koonal, Longworth Louise, Devercelli Giovanna, Ayodele Olulade

机构信息

Royal Free London NHS Foundation Trust, University College London, United Kingdom.

PHMR, London, United Kingdom.

出版信息

J Health Econ Outcomes Res. 2023 Apr 10;10(1):80-88. doi: 10.36469/001c.71344. eCollection 2023.

DOI:10.36469/001c.71344
PMID:37064293
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10095067/
Abstract

Health state utilities are measures of health-related quality of life that reflect the value placed on improvements in patients' health status and are necessary for estimation of quality-adjusted life-years. Health state utility data on Fabry disease (FD) are limited. In this study we used vignette (scenario) construction and valuation to develop health state utilities. The aim of this study was to use vignette construction and valuation to estimate health state utility values suitable for inclusion in economic models of FD treatments. Health state vignettes were developed from semistructured qualitative telephone interviews with patients with FD and informed by published literature and input from an expert. Each vignette was valued in an online survey by members of the United Kingdom (UK) general population using the composite time trade-off (TTO) method, which aims to determine the time the respondent would trade to live in full health compared with each impaired health state. Eight adults (50% women) with FD from the UK were interviewed. They were recruited via various approaches, including patient organizations and social media. The interviewees' responses, evidence from published literature, and input from a clinical expert informed the development of 6 health state vignettes (pain, moderate clinically evident FD [CEFD], severe CEFD, end-stage renal disease [ESRD], stroke, and cardiovascular disease [CVD]) and 3 combined health states (severe CEFD + ESRD, severe CEFD + CVD, and severe CEFD + stroke). A vignette valuation survey was administered to 1222 participants from the UK general population who were members of an external surveying organization and agreed to participate in this study; 1175 surveys were successfully completed and included in the analysis. Responses to TTO questions were converted into utility values for each health state. Pain was the highest valued health state (0.465), and severe CEFD + ESRD was the lowest (0.033). Overall, mean utility values declined as the severity of the vignettes increased, indicating that respondents were more willing to trade life-years to avoid a severe health state. Health state vignettes reflect the effects of FD on all major health-related quality-of-life domains and may help to support economic modeling for treatment of FD.

摘要

健康状态效用是衡量与健康相关的生活质量的指标,反映了对患者健康状况改善的重视程度,是估计质量调整生命年所必需的。关于法布里病(FD)的健康状态效用数据有限。在本研究中,我们使用情景构建和赋值来制定健康状态效用。本研究的目的是使用情景构建和赋值来估计适合纳入FD治疗经济模型的健康状态效用值。健康状态情景是通过对FD患者进行半结构化定性电话访谈,并参考已发表的文献和专家意见而制定的。每个情景在在线调查中由英国普通人群成员使用复合时间权衡(TTO)方法进行赋值,该方法旨在确定受访者为了完全健康地生活而愿意与每种受损健康状态进行交换的时间。对来自英国的8名成年FD患者(50%为女性)进行了访谈。他们是通过多种途径招募的,包括患者组织和社交媒体。受访者的回答、已发表文献的证据以及临床专家的意见为6种健康状态情景(疼痛、中度临床显性FD [CEFD]、重度CEFD、终末期肾病 [ESRD]、中风和心血管疾病 [CVD])和3种组合健康状态(重度CEFD + ESRD、重度CEFD + CVD和重度CEFD + 中风)的制定提供了依据。对来自英国普通人群的1222名参与者进行了情景赋值调查,这些参与者是外部调查组织的成员并同意参与本研究;1175份调查问卷成功完成并纳入分析。对TTO问题的回答被转换为每种健康状态的效用值。疼痛是效用值最高的健康状态(0.465),而重度CEFD + ESRD是最低的(0.033)。总体而言,随着情景严重程度的增加,平均效用值下降,这表明受访者更愿意用生命年进行交换以避免严重的健康状态。健康状态情景反映了FD对所有主要与健康相关的生活质量领域的影响,可能有助于支持FD治疗的经济建模。

相似文献

1
Estimation of Health State Utility Values in Fabry Disease Using Vignette Development and Valuation.使用情景开发和评估法估计法布里病的健康状态效用值
J Health Econ Outcomes Res. 2023 Apr 10;10(1):80-88. doi: 10.36469/001c.71344. eCollection 2023.
2
Estimating health state utilities in primary hyperoxaluria type 1: a valuation study.1型原发性高草酸尿症健康状态效用评估:一项估值研究。
J Med Econ. 2023 Jan-Dec;26(1):386-393. doi: 10.1080/13696998.2023.2176678.
3
Quality of Life with Late-Onset Pompe Disease: Qualitative Interviews and General Public Utility Estimation in the United Kingdom.晚发性庞贝病患者的生活质量:英国的定性访谈与一般公众效用评估
J Health Econ Outcomes Res. 2023 Mar 3;10(1):41-50. doi: 10.36469/001c.68157. eCollection 2023.
4
Efficient Designs for Valuation Studies That Use Time Tradeoff (TTO) Tasks to Map Latent Utilities from Discrete Choice Experiments to the Interval Scale: Selection of Health States for TTO Tasks.利用时间权衡(TTO)任务将离散选择实验中的潜在效用映射到区间量表的估值研究的高效设计:TTO任务的健康状态选择
Med Decis Making. 2023 Apr;43(3):387-396. doi: 10.1177/0272989X231159381. Epub 2023 Mar 3.
5
Assessment of health state utilities associated with adult and pediatric acid sphingomyelinase deficiency (ASMD).成人和儿童酸性鞘磷脂酶缺乏症(ASMD)相关健康状态效用的评估。
Eur J Health Econ. 2024 Nov;25(8):1437-1448. doi: 10.1007/s10198-023-01667-7. Epub 2024 Feb 27.
6
Time Trade-Off Utilities for Hereditary Angioedema Health and Caregiver States.遗传性血管性水肿健康状态与照料者状态的时间权衡效用
Pharmacoecon Open. 2022 Mar;6(2):231-239. doi: 10.1007/s41669-021-00302-6. Epub 2021 Sep 17.
7
A health state utility valuation study to assess the impact of treatment mode of administration in Gaucher disease.一项健康状态效用值评估研究,旨在评估戈谢病治疗方式给药的影响。
Orphanet J Rare Dis. 2018 Sep 10;13(1):159. doi: 10.1186/s13023-018-0903-6.
8
Defining Utility Values for Chorea Health States in Patients with Huntington's Disease.定义亨廷顿舞蹈症患者舞蹈病健康状态的效用值。
Adv Ther. 2022 Apr;39(4):1784-1793. doi: 10.1007/s12325-022-02046-z. Epub 2022 Feb 23.
9
Estimating health state utilities associated with a rare disease: familial chylomicronemia syndrome (FCS).评估与罕见疾病相关的健康状态效用值:家族性乳糜微粒血症综合征(FCS)。
J Med Econ. 2020 Sep;23(9):978-984. doi: 10.1080/13696998.2020.1776719. Epub 2020 Jul 1.
10
Health state utility values for metastatic pancreatic cancer using a composite time trade-off based on the vignette-based approach in Japan.基于日本 vignette 法的复合时间权衡法得出的转移性胰腺癌的健康状态效用值。
Health Econ Rev. 2022 Dec 24;12(1):63. doi: 10.1186/s13561-022-00413-8.

引用本文的文献

1
Health State Utility Values in Fabry Disease: Insights from the Pegunigalsidase Alfa Clinical Trials.法布里病的健康状态效用值:来自聚乙二醇化α-半乳糖苷酶临床试验的见解。
Adv Ther. 2025 Mar;42(3):1421-1434. doi: 10.1007/s12325-024-03095-2. Epub 2025 Jan 23.

本文引用的文献

1
Prompt Agalsidase Alfa Therapy Initiation is Associated with Improved Renal and Cardiovascular Outcomes in a Fabry Outcome Survey Analysis.提示:阿加糖酶阿尔法治疗的启动与 Fabry 结局调查分析中的改善的肾脏和心血管结局相关。
Drug Des Devel Ther. 2021 Aug 16;15:3561-3572. doi: 10.2147/DDDT.S313789. eCollection 2021.
2
Vignette-Based Utilities: Usefulness, Limitations, and Methodological Recommendations.基于小插曲的实用工具:实用性、局限性和方法学建议。
Value Health. 2021 Jun;24(6):812-821. doi: 10.1016/j.jval.2020.12.017. Epub 2021 May 14.
3
The relation between EQ-5D and fatigue in a Dutch general population sample: an explorative study.
EQ-5D 与荷兰普通人群样本疲劳之间的关系:一项探索性研究。
Health Qual Life Outcomes. 2021 Apr 29;19(1):135. doi: 10.1186/s12955-021-01771-3.
4
Effects of Baseline Left Ventricular Hypertrophy and Decreased Renal Function on Cardiovascular and Renal Outcomes in Patients with Fabry Disease Treated with Agalsidase Alfa: A Fabry Outcome Survey Study.基线左心室肥厚和肾功能下降对接受阿加糖酶α治疗的法布病患者心血管和肾脏结局的影响:一项法布病结局调查研究。
Clin Ther. 2020 Dec;42(12):2321-2330.e0. doi: 10.1016/j.clinthera.2020.10.007. Epub 2020 Nov 17.
5
Analysis of Renal and Cardiac Outcomes in Male Participants in the Fabry Outcome Survey Starting Agalsidase Alfa Enzyme Replacement Therapy Before and After 18 Years of Age.分析 18 岁前和后开始用阿加糖酶α酶替代疗法的 Fabry 结局调查中男性参与者的肾脏和心脏结局。
Drug Des Devel Ther. 2020 Jun 3;14:2149-2158. doi: 10.2147/DDDT.S249433. eCollection 2020.
6
Depressive symptoms in Fabry disease: the importance of coping, subjective health perception and pain.法布瑞病患者的抑郁症状:应对方式、主观健康感知和疼痛的重要性。
Orphanet J Rare Dis. 2020 Jan 28;15(1):28. doi: 10.1186/s13023-020-1307-y.
7
Cardio- Renal Outcomes With Long- Term Agalsidase Alfa Enzyme Replacement Therapy: A 10- Year Fabry Outcome Survey (FOS) Analysis.长期阿加糖酶α酶替代疗法的心血管肾脏结局:一项为期10年的法布里病结局调查(FOS)分析。
Drug Des Devel Ther. 2019 Oct 25;13:3705-3715. doi: 10.2147/DDDT.S207856. eCollection 2019.
8
Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force Report.健康状态效用值在成本效果模型中的识别、评价和应用:ISPOR 疗效研究实践报告
Value Health. 2019 Mar;22(3):267-275. doi: 10.1016/j.jval.2019.01.004.
9
Phenotype, disease severity and pain are major determinants of quality of life in Fabry disease: results from a large multicenter cohort study.表型、疾病严重程度和疼痛是法布瑞病患者生活质量的主要决定因素:来自一项大型多中心队列研究的结果。
J Inherit Metab Dis. 2018 Jan;41(1):141-149. doi: 10.1007/s10545-017-0095-6. Epub 2017 Oct 16.
10
Experience-based utility and own health state valuation for a health state classification system: why and how to do it.基于经验的效用和自身健康状况对健康状况分类系统的评估:为什么要这样做以及如何去做。
Eur J Health Econ. 2018 Jul;19(6):881-891. doi: 10.1007/s10198-017-0931-5. Epub 2017 Oct 11.